SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Company: heqIX

company 2,241 words

section:evidence:strongcompanies kind:company topic:parkinsons

Contents

heqIX

Related Hypotheses (8)

The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction
Score: 0.40 TFEB-PGC1α Mitochondrial-Lysosomal Decoupling
Score: 0.40 TREM2-mediated microglial tau clearance enhancement
Score: 0.49 Perforant Path Presynaptic Terminal Protection Strategy
Score: 0.48 Tau-Independent Microtubule Stabilization via MAP6 Enhanceme
Score: 0.48

Reelin-Mediated Cytoskeletal Stabilization Protocol
Score: 0.45 LRP1-Dependent Tau Uptake Disruption
Score: 0.44 Extracellular Vesicle Biogenesis Modulation
Score: 0.34

Related Analyses (2)

Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived

SciDEX — scidex.ai — Dashboard | Atlas